Results 151 to 160 of about 9,715 (199)

I15 Laparoscopic Duhamel Pull-Through Procedure

2013
Van Der Zee David C, David C Van Der Zee   +1 more
exaly   +2 more sources

I15 Electronic clinical dashboard for assessing symptomatic progression in huntington’s disease

Journal of Neurology, Neurosurgery & Psychiatry, 2016
Background Huntington’s disease (HD) is characterised by progressive motor, cognitive and psychiatric symptoms. However, it is difficult for clinicians to identify whether clinical features in an individual with manifest HD are progressing at a rate comparable to that expected for peers with similar CAG repeat length (CAGn) and age. Aims To develop
Thomas Walker, Christopher Kipps, Boyd Ghosh   +2 more
openaire   +1 more source

I15 Necessity and benefit of thrombophilia screening?

Blood Reviews, 2007
Several genetic and acquired risk factors for the development of venous thrombosis are known. Venous thrombosis is recognized as a multicausal disease caused by genetic and environmental factors. The identification of inherited prothrombotic risk factors has led to extensive laboratory screening for thrombophilia among patients and their family members.
openaire   +1 more source

I15 Nootropic effect and action mechanisms of Ginsenoside Rg1, a smart drug candidate

Biochemical Pharmacology, 2017
Cognitive drugs can be classified into two major categories: one improving cognitive impairment in patients and the other increasing mental ability or intelligence capacity in healthy people with neither toxicity nor serious side effects even after long term use.
Juntian Zhang, Shifeng Chu
openaire   +1 more source

I15 Sleep In Patients With Huntington's Disease: Interim Results From A Polysomnographic Study

Journal of Neurology, Neurosurgery & Psychiatry, 2014
Background 88% of HD patients report to suffer from sleep problems. A reduction in REM sleep as well as an increased REM sleep latency has already been described in previous studies. A recent study has shown, that these symptoms can also be observed in treated HD patients and even in still asymptomatic gene carriers.
E. Hametner, D. Gabelia, B. Frauscher, K. Seppi, G. Wenning, A. Hussl, W. Poewe, B. Hogl   +7 more
openaire   +1 more source

I15 The drosophila gut: A new paradigm for epithelial immune response

Cytokine, 2012
Reference EPFL-CONF-184369doi:10.1016/j.cyto.2012.06.305View record in Web of Science Record created on 2013-02-27, modified on 2017-05 ...
openaire   +1 more source

Energy assignments for the I15/24 and S3/24 multiplets of the Er3+ ion in (Er0.05Y0.95)2BaZnO5

Journal of Applied Physics, 2001
The absorption and emission spectra between the I15/24 and S3/24 multiplets of the Er3+ ion in (Er0.05Y0.95)2BaZnO5 are recorded. From these spectra we have demonstrated the occupancy of two nonequivalent positions by the Er3+ ion in the sample. Time decay measurement, emission versus temperature analysis, and selective site excitation were made to ...
G. K. Cruz, R. A. Carvalho, H. C. Basso
openaire   +1 more source

I15 Inhibition of S1P degradation is beneficial in the transgenic R6/2 mouse model of huntington disease

Experimental therapeutics – preclinical, 2018
Background Huntington’s disease (HD) is the most common neurodegenerative disorder with no effective cure currently available. Over the past few years our research has shown that alterations in sphingolipid metabolism represent a critical determinant in the pathogenesis of the disease.
Alba Di Pardo, Salvatore Castaldo, Enrico Amico, Luca Capocci, Giuseppe Pepe, Vittorio Maglione   +5 more
openaire   +1 more source

Sélection de modes dďun laser Fabry-Pérot InGaAsP à 1,5 µm par la transition I15/2 -→I13/2 de Er3+

Annales Des Télécommunications, 1993
LĽarticle etudie la selection de modes dľun laser Fabry-Perot InGaAsP multimode a 1,5 µm par lľutilisation des absorptions atomiques de ľion Er3+, Cette nouvelle technique consiste a inserer des echantillons dopes Er3+ dans la cavite laser. Le processus de selection de mode n’est pas lie a un effet Fabry-Perot de ces echantillons, mais a lľabsorption ...
Bei Wen Zhou, François Auzel
openaire   +1 more source

Multi-pathways-mediated mechanisms of selenite reduction and elemental selenium nanoparticles biogenesis in the yeast-like fungus Aureobasidium melanogenum I15

Journal of Hazardous Materials
Selenium (Se) plays a critical role in diverse biological processes and is widely used across manufacturing industries. However, the contamination of Se oxyanions also poses a major public health concern. Microbial transformation is a promising approach to detoxify Se oxyanions and produce elemental selenium nanoparticles (SeNPs) with versatile ...
Si-Jia, Xue, Xin-Tong, Zhang, Xiao-Chen, Li, Fang-Yuan, Zhao, Xian, Shu, Wen-Wen, Jiang, Jin-Yong, Zhang   +6 more
openaire   +2 more sources